Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion type Assertion NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_head.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion description "[In this review, we outline these findings including: molecular pathways used by BRAF, the importance in nonmalignant neoplasms, histologic associations, the relationship of BRAF to KIT and NRAS mutations, and their impact on survival, as well as resistance mechanisms to BRAF inhibitors employed by melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_provenance.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion evidence source_evidence_literature NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_provenance.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion SIO_000772 23414474 NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_provenance.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion wasDerivedFrom befree-2016 NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_provenance.
- NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_assertion wasGeneratedBy ECO_0000203 NP1053410.RAX4M7S8O72COByf3RO_C6MQr_YXTsTmVnGiCqkcEJHGw130_provenance.